US OptionsDetailed Quotes
AMED250117C85000
- 7.20
- +0.80+12.50%
15min DelayClose Jan 17 16:00 ET
7.20High7.20Low
7.20Open6.40Pre Close1 Volume1.03K Open Interest85.00Strike Price720.00Turnover6261.85%IV0.32%PremiumJan 17, 2025Expiry Date6.91Intrinsic Value100Multiplier-2DDays to Expiry0.29Extrinsic Value100Contract SizeAmericanOptions Type0.9254Delta0.0275Gamma13.13Leverage Ratio-1215.1170Theta0.0000Rho12.15Eff Leverage0.0001Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?